Litcius/Paper detail

New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis

Andrew D.J. Pearson, Claudia Rössig, Crystal L. Mackall, Nirali N. Shah, André Baruchel, Sam Daems, John Anderson, Andrea Biondi, Nick Bird, Nicole Bodmer, Erica Brivio, Jochen Buechner, Friso Calkoen, Todd M. Cooper, Teresa de Rojas, Elizabeth Fox, Rebecca Gardner, Sara Ghorashian, Delphine Heenen, Marianne Ifversen, Elad Jacoby, Manel Juan, Leona Knox, Krishna V. Komanduri, Jérôme Larghero, Franco Locatelli, Donna Ludwinski, Robbie G. Majzner, Joe McDonough, Véronique Minard‐Colin, Karsten Nysom, Alberto S. Pappo, Julie R. Park, Waseem Qasim, Concetta Quintarelli, Susana Rives, Rayne H. Rouce, Nicole Scobie, Christian Seitz, Sarah K. Tasian, Brenda J. Weigel, Susan Weiner, C. Michel Zwaan, Gilles Vassal

2025The Lancet Oncology8 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCancerInternal medicineCAR-T cell therapy researchBiomedical and Engineering Education
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis | Litcius